Aethlon Medical Announces European Patent To Remove Viruses From Blood Daily Markets (press release) It is a leading cause of cirrhosis and liver transplantation. The FDA approved Hemopurifier therapy feasibility study calls for a single-site enrollment of ten HCV-infected end-stage renal disease (ESRD) patients who have not received any ... |
